This National Women’s Health Week, Alkermes’ Director of Corporate and R&D Communications, Gretchen Murphy, shares her personal story and why regular cancer screenings are vital. This NWHW, we encourage all women to learn more about early cancer detection and screenings: https://bit.ly/37zpfGm
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
KEYWORDS: NASDAQ:ALKS, Alkermes, Cancer, Gretchen Murphy, National Women’s Health Week